(2019). Corrigendum to Real-world comparative effectiveness of nab-paclitaxel plus gemcitabine versus FOLFIRINOX in advanced pancreatic cancer: A systematic review. Ther Adv Med Oncol.
Chicago Style citaat"Corrigendum to Real-world Comparative Effectiveness of Nab-paclitaxel plus Gemcitabine Versus FOLFIRINOX in Advanced Pancreatic cancer: A Systematic Review." Ther Adv Med Oncol 2019.
MLA citatie"Corrigendum to Real-world Comparative Effectiveness of Nab-paclitaxel plus Gemcitabine Versus FOLFIRINOX in Advanced Pancreatic cancer: A Systematic Review." Ther Adv Med Oncol 2019.
Let op: Deze citaties zijn niet altijd 100% accuraat.